89 related articles for article (PubMed ID: 15228660)
21. [Immunophenotypic and clinical characteristic analysis of NPM1 mutated acute myeloid leukemia with a normal karyotype].
Liu YR; Lai YY; Chang Y; Ruan GR; Qin YZ; Wang YZ; Zhu HH; Shi HX; Jiang B; Jiang H; Jiang Q; Hao L; Li JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1385-9. PubMed ID: 24370016
[TBL] [Abstract][Full Text] [Related]
22. Association between P-glycoprotein and lymphoid antigen expression on myeloblasts versus therapy response and survival in de novo acute myeloid leukemia: long-term follow-up results.
Machaczka M; Wahlin BE; Piatkowska-Jakubas B; Rucinska M; Jurczak W; Balana-Nowak A; Klimkowska M; Hägglund H; Skotnicki AB
Med Oncol; 2012 Sep; 29(3):2070-6. PubMed ID: 21861206
[TBL] [Abstract][Full Text] [Related]
23. [Clinical characteristics and immunophenotypes of mixed-lineage acute leukemia].
Li XL; Li R; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):636-9. PubMed ID: 17605883
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
25. [Study on the clinical characteristics of biphenotypic acute leukemia].
Mi Y; Bian S; Meng Q; Xue Y; Yu M; Chen G; Li D; Chen Y; Qian L
Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):352-4. PubMed ID: 11877003
[TBL] [Abstract][Full Text] [Related]
26. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
[TBL] [Abstract][Full Text] [Related]
27. [Immunophenotyping characteristics of AML and their correlation with the curative effects].
Yang LL; Liu X; Li Q; Zhu XY; Wang XB; Zhu WB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):1-5. PubMed ID: 24598640
[TBL] [Abstract][Full Text] [Related]
28. Detection of minimal residual disease in acute myeloid leukemia.
Gerhartz HH; Schmetzer H
Leukemia; 1990 Jul; 4(7):508-16. PubMed ID: 1695705
[TBL] [Abstract][Full Text] [Related]
29. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
[TBL] [Abstract][Full Text] [Related]
30. [Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study].
Reinhardt D; Langebrake C; Creutzig U; Vormoor J; Brune C; Thorwesten M; Ingiliz P; Hrusak O; Dworzak M; Griesinger F
Klin Padiatr; 2002; 214(4):179-87. PubMed ID: 12165899
[TBL] [Abstract][Full Text] [Related]
31. CD34 expression fails to predict the outcome in adult acute myeloid leukemia.
Ciolli S; Leoni F; Caporale R; Pascarella A; Salti F; Rossi-Ferrini P
Haematologica; 1993; 78(3):151-5. PubMed ID: 7690733
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells.
Terstappen LW; Safford M; Unterhalt M; Könemann S; Zurlutter K; Piechotka K; Drescher M; Aul C; Büchner T; Hiddemann W
Leukemia; 1992 Oct; 6(10):993-1000. PubMed ID: 1383649
[TBL] [Abstract][Full Text] [Related]
33. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH
Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
[TBL] [Abstract][Full Text] [Related]
34. Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance.
Smith FO; Lampkin BC; Versteeg C; Flowers DA; Dinndorf PA; Buckley JD; Woods WG; Hammond GD; Bernstein ID
Blood; 1992 May; 79(9):2415-22. PubMed ID: 1571553
[TBL] [Abstract][Full Text] [Related]
35. [Immunophenotypic study of acute myeloid leukemia (AML): biological significance and prognostic implications].
Rigolin GM; Latorraca A; Moretti S; Previati R; Lanza F
Boll Soc Ital Biol Sper; 1993 May; 69(5):301-5. PubMed ID: 8129911
[TBL] [Abstract][Full Text] [Related]
36. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
37. Features and clinical outcomes in 40 patients with mixed-lineage acute leukemia in a single center.
Zhang C; Zhang X; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Zeng DF; Peng XG; Sun AH
Hematology; 2013 Nov; 18(6):309-14. PubMed ID: 23510508
[TBL] [Abstract][Full Text] [Related]
38. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
39. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia.
Aref S; Salama O; Al-Tonbary Y; Mansour A
Hematology; 2004 Apr; 9(2):113-21. PubMed ID: 15203866
[TBL] [Abstract][Full Text] [Related]
40. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
